Active Ingredient(s):Ropeginterferon alfa-2b-njft FDA Approved: * November 12, 2021 Pharm Company: *PHARMAESSENTIA CORP
Ropeginterferon alfa-2b, sold under the brand name Besremi, is a medication used to treat polycythemia vera. It is an interferon. It is given by injection.
The most common side effects include low levels of white blood cells and platelets (blood components that help the blood to clot), muscle and joint pain, tiredness, flu-like symptoms and in...
* May have multiple approval dates, manufacturers, or labelers.